162 related articles for article (PubMed ID: 23624506)
21. The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo.
Booth L; Roberts JL; Sander C; Lee J; Kirkwood JM; Poklepovic A; Dent P
Oncotarget; 2017 Mar; 8(10):16367-16386. PubMed ID: 28146421
[TBL] [Abstract][Full Text] [Related]
22. Raloxifene increases proliferation and up-regulates telomerase activity in human umbilical vein endothelial cells.
Doshida M; Ohmichi M; Tsutsumi S; Kawagoe J; Takahashi T; Du B; Mori-Abe A; Ohta T; Saitoh-Sekiguchi M; Takahashi K; Kurachi H
J Biol Chem; 2006 Aug; 281(34):24270-8. PubMed ID: 16798746
[TBL] [Abstract][Full Text] [Related]
23. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
Fang J; Ding M; Yang L; Liu LZ; Jiang BH
Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
[TBL] [Abstract][Full Text] [Related]
24. Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma.
Kunisada M; Budiyanto A; Bito T; Nishigori C; Ueda M
Br J Dermatol; 2005 Mar; 152(3):435-43. PubMed ID: 15787811
[TBL] [Abstract][Full Text] [Related]
25. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
[TBL] [Abstract][Full Text] [Related]
26. Expression of human telomerase reverse transcriptase mediates the senescence of mesenchymal stem cells through the PI3K/AKT signaling pathway.
Zhao Q; Wang XY; Yu XX; Zhai YX; He X; Wu S; Shi YA
Int J Mol Med; 2015 Sep; 36(3):857-64. PubMed ID: 26178664
[TBL] [Abstract][Full Text] [Related]
27. HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity.
Sharma V; Koul N; Joseph C; Dixit D; Ghosh S; Sen E
J Cell Mol Med; 2010 Aug; 14(8):2151-61. PubMed ID: 19583803
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor-alpha enhances neutrophil adhesiveness: induction of vascular cell adhesion molecule-1 via activation of Akt and CaM kinase II and modifications of histone acetyltransferase and histone deacetylase 4 in human tracheal smooth muscle cells.
Lee CW; Lin CC; Luo SF; Lee HC; Lee IT; Aird WC; Hwang TL; Yang CM
Mol Pharmacol; 2008 May; 73(5):1454-64. PubMed ID: 18227124
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the PI3K/AKT pathway reduces tumor necrosis factor-alpha production in the cellular response to wear particles in vitro.
Huang JB; Ding Y; Huang DS; Liang AJ; Zeng WK; Zeng ZP; Qin CQ; Barden B
Artif Organs; 2013 Mar; 37(3):298-307. PubMed ID: 23330804
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells.
Wang Y; Yan W; Lu X; Qian C; Zhang J; Li P; Shi L; Zhao P; Fu Z; Pu P; Kang C; Jiang T; Liu N; You Y
Eur J Cell Biol; 2011 Aug; 90(8):642-8. PubMed ID: 21616556
[TBL] [Abstract][Full Text] [Related]
31. Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription.
Endoh T; Tsuji N; Asanuma K; Yagihashi A; Watanabe N
Exp Cell Res; 2005 May; 305(2):300-11. PubMed ID: 15817155
[TBL] [Abstract][Full Text] [Related]
32. Fucoidan Induces ROS-Dependent Apoptosis in 5637 Human Bladder Cancer Cells by Downregulating Telomerase Activity via Inactivation of the PI3K/Akt Signaling Pathway.
Han MH; Lee DS; Jeong JW; Hong SH; Choi IW; Cha HJ; Kim S; Kim HS; Park C; Kim GY; Moon SK; Kim WJ; Hyun Choi Y
Drug Dev Res; 2017 Feb; 78(1):37-48. PubMed ID: 27654302
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.
Peek GW; Tollefsbol TO
Exp Cell Res; 2016 May; 344(1):95-102. PubMed ID: 27017931
[TBL] [Abstract][Full Text] [Related]
34. Camptothecin induces c-Myc- and Sp1-mediated hTERT expression in LNCaP cells: Involvement of reactive oxygen species and PI3K/Akt.
Dilshara MG; Jayasooriya RGPT; Choi YH; Kim GY
Food Chem Toxicol; 2019 May; 127():53-60. PubMed ID: 30851366
[TBL] [Abstract][Full Text] [Related]
35. AKT activation and telomerase reverse transcriptase expression are concurrently associated with prognosis of gastric cancer.
Sasaki T; Kuniyasu H; Luo Y; Kitayoshi M; Tanabe E; Kato D; Shinya S; Fujii K; Ohmori H; Yamashita Y
Pathobiology; 2014; 81(1):36-41. PubMed ID: 23969493
[TBL] [Abstract][Full Text] [Related]
36. MAGI3 Suppresses Glioma Cell Proliferation via Upregulation of PTEN Expression.
Ma Q; Zhang Y; Meng R; Xie KM; Xiong Y; Lin S; He ZL; Tao T; Yang Y; Zhao JZ; He JQ
Biomed Environ Sci; 2015 Jul; 28(7):502-9. PubMed ID: 26248734
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
Kim SN; Kim NH; Lee W; Seo DW; Kim YK
Mol Cancer Res; 2009 May; 7(5):735-44. PubMed ID: 19435809
[TBL] [Abstract][Full Text] [Related]
38. Mistletoe lectin induces apoptosis and telomerase inhibition in human A253 cancer cells through dephosphorylation of Akt.
Choi SH; Lyu SY; Park WB
Arch Pharm Res; 2004 Jan; 27(1):68-76. PubMed ID: 14969342
[TBL] [Abstract][Full Text] [Related]
39. Induction of bovine articular chondrocyte senescence with oxidized low-density lipoprotein through lectin-like oxidized low-density lipoprotein receptor 1.
Zushi S; Akagi M; Kishimoto H; Teramura T; Sawamura T; Hamanishi C
Arthritis Rheum; 2009 Oct; 60(10):3007-16. PubMed ID: 19790061
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.
Kunnimalaiyaan M; Ndiaye M; Chen H
Surgery; 2006 Dec; 140(6):1009-14; discussion 1014-5. PubMed ID: 17188151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]